Delivery Order SPE2DR25D2001-SPE2DR26FBGP5
- Not listed
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 20, 2026, for the supply of Albuterol HFA 90 microgram inhaler (8.5 grams) with a ceiling value of $1,393.92. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, utilizing performance in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,166.52 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG inhaler (8.5 grams) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,172.60 to Amerisourcebergen Drug Corp on January 8, 2026, for the supply of Albuterol HFA 90 micrograms inhalers (8.5 grams). This firm fixed-price delivery order is scheduled for completion by January 9, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, leveraging the contractor's existing indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Albuterol HFA 90 MCG Inhaler in 8.5GM units, valued at $1,518.96. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Albuterol HFA 90 MCG inhalers in 8.5-gram units with a ceiling value of $4,138.56. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by November 4, 2025, and the work will be performed at AmerisourceBergen's corporate office location in...
- On January 22, 2026, the Defense Logistics Agency awarded a $1,045.92 delivery order to AmerisourceBergen Drug Corp for Albuterol HFA 90 microgram inhalers (8.5 grams) with a completion date of January 23, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $1,400.36 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhalers (8.5 grams) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 gm) valued at $1,241.52. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and carries an ultimate completion date of December 5, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,393.92 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 8.5-gram units. This contract, awarded on January 9, 2026, is a firm fixed-price delivery order with an ultimate completion date of January 12, 2026 and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award utilized no set-aside provisions, indicating the contract was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) with a ceiling value of $4,328.64. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBGP5Delivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 22, 2026, for the supply of Albuterol HFA 90 MCG Inhalers in 8.5-gram units, with a contract ceiling value of $1,247.04 and an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. The award falls under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary procurement vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor and critical federal healthcare vendor, regularly supplies prescription medications, over-the-counter drugs, and medical devices across multiple therapeutic domains to support military treatment facilities and veteran healthcare systems. This albuterol inhaler delivery represents a routine pharmaceutical fulfillment under the company's broad-based supply agreement with DLA, enabling the agency to maintain adequate respiratory medication inventory for its healthcare operations. The short performance timeline indicates this is a time-sensitive resupply order for an essential, commonly prescribed bronchodilator medication used extensively in military and federal medical settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/21/26 |